Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - potential impact on therapeutic decisions

zu Verbundenen Objekten

Abstract: Synthetic cannabinoids (SCs) have become established drugs of abuse. They play an increasing role in drug therapy, where abstinence control testing is required. Differentiation between recent drug uptake and uptake in the distant past is important for drug therapy. This study aimed to evaluate the detection window of a metabolite commonly used as a consumption marker for AB‐FUBINACA and AMB‐FUBINACA (synonym: FUB‐AMB) in urine analysis. The acidic hydrolysis metabolite was quantified in urine samples of a drug user by applying a validated analytical method. The concentration profile of the metabolite was correlated with usage data of the subject. Pharmacokinetic properties of AB‐FUBINACA were collected by analysis of serum and urine samples from a controlled administration study (single oral ingestion of AB‐FUBINACA). Thirteen urine samples were taken without advance notice over 2 years. The metabolite was detected in the first urine sample at 0.77 ng/mg creatinine and subsequently in concentrations ranging from 0.06 to 0.29 ng/mg creatinine. Usage data showed credible abstinence from SCs during this period. The pharmacokinetic properties observed within the controlled self‐administration study supported the hypothesis of distribution into deeper compartments and long‐lasting elimination (serum concentration–time curve showing biphasic kinetics). An elimination phase of over 1 year after the last drug uptake seems plausible in cases of extensive consumption. To avoid misinterpretation of positive findings, we recommend testing patients with known SC use at the beginning of the abstinence program and to re‐test continuously at short time intervals. These data enable the correct interpretation of analytical findings

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Drug testing and analysis. - 12, 3 (2020) , 391-396, ISSN: 1942-7611

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2020
Urheber

DOI
10.1002/dta.2770
URN
urn:nbn:de:bsz:25-freidok-1552170
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Entstanden

  • 2020

Ähnliche Objekte (12)

Fettsäureethylester als Marker exzessiven Alkoholkonsums : analytische Bestimmung im Haar und in der Hautoberflächenlipiden mittels Headspace-Festphasenmikroextraktion und Gaschromatographie-Massenspektrometrie

Hochschulschrift

Fettsäureethylester als Marker exzessiven Alkoholkonsums : analytische Bestimmung im Haar und in der Hautoberflächenlipiden mittels Headspace-Festphasenmikroextraktion und Gaschromatographie-Massenspektrometrie

Missbrauch neuer synthetischer Cannabinoide im Maßregelvollzug

Missbrauch neuer synthetischer Cannabinoide im Maßregelvollzug

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE

Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists

Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists

Nachweis von Drogen und Arzneistoffen in dentalem Biofilm

Nachweis von Drogen und Arzneistoffen in dentalem Biofilm

Editorial: Toxicological profiles and pharmacological properties of synthetic cannabinoids: from chemical and analytical issues to fatal and non-fatal intoxications

Editorial: Toxicological profiles and pharmacological properties of synthetic cannabinoids: from chemical and analytical issues to fatal and non-fatal intoxications

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?

Empfehlungen zum Umgang mit Alkohol

Empfehlungen zum Umgang mit Alkohol

Pharmacological assessment of synthetic cannabinoid receptor agonists, their semi-systematic naming and analytical characterization of novel psychoactive substances

Pharmacological assessment of synthetic cannabinoid receptor agonists, their semi-systematic naming and analytical characterization of novel psychoactive substances

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes : : comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes : : comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

Verbundene Objekte